PDX1 and neoplasm: To optimize and measure the platform performance characteristics, we first utilized a tumor-derived cell line (PD7591) from a genetically engineered mouse model of pancreatic cancer (Pdx1-Cre, KrasLSL-G12D, p53L/+, RosaYFP/YFP (KPCY))49.